NEW AMSTERDAM INVEST NV (NAI.AS) Stock Fundamental Analysis

AMS:NAI • NL0015000CG2

8.95 EUR
+0.15 (+1.7%)
Last: Feb 12, 2026, 07:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NAI. NAI was compared to 0 industry peers in the Unkown industry. NAI has a bad profitability rating. Also its financial health evaluation is rather negative. NAI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year NAI was profitable.
  • In the past year NAI had a positive cash flow from operations.
NAI.AS Yearly Net Income VS EBIT VS OCF VS FCFNAI.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

1.2 Ratios

Industry RankSector Rank
ROA 0.89%
ROE 2.58%
ROIC 5.55%
ROA(3y)-2.71%
ROA(5y)N/A
ROE(3y)-3.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NAI.AS Yearly ROA, ROE, ROICNAI.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 5 -5 -10

1.3 Margins

Industry RankSector Rank
OM 54.47%
PM (TTM) 7.01%
GM 63.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NAI.AS Yearly Profit, Operating, Gross MarginsNAI.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50 -100

0

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NAI is destroying value.
  • The number of shares outstanding for NAI remains at a similar level compared to 1 year ago.
  • NAI has a worse debt/assets ratio than last year.
NAI.AS Yearly Shares OutstandingNAI.AS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 1M 2M 3M 4M 5M
NAI.AS Yearly Total Debt VS Total AssetsNAI.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • NAI has an Altman-Z score of 0.60. This is a bad value and indicates that NAI is not financially healthy and even has some risk of bankruptcy.
  • The Debt to FCF ratio of NAI is 29.70, which is on the high side as it means it would take NAI, 29.70 years of fcf income to pay off all of its debts.
  • NAI has a Debt/Equity ratio of 1.52. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.52
Debt/FCF 29.7
Altman-Z 0.6
ROIC/WACC0.94
WACC5.93%
NAI.AS Yearly LT Debt VS Equity VS FCFNAI.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • NAI has a Current Ratio of 0.69. This is a bad value and indicates that NAI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • A Quick Ratio of 0.69 indicates that NAI may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.69
Quick Ratio 0.69
NAI.AS Yearly Current Assets VS Current LiabilitesNAI.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M

2

3. Growth

3.1 Past

  • NAI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 415.44%, which is quite impressive.
  • NAI shows a strong growth in Revenue. In the last year, the Revenue has grown by 82.26%.
EPS 1Y (TTM)415.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-63.16%
Revenue 1Y (TTM)82.26%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%99.67%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NAI.AS Yearly Revenue VS EstimatesNAI.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2M 4M 6M 8M 10M

0

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 31.96, the valuation of NAI can be described as expensive.
  • NAI's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.97.
Industry RankSector Rank
PE 31.96
Fwd PE N/A
NAI.AS Price Earnings VS Forward Price EarningsNAI.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 21.13
EV/EBITDA 12.75
NAI.AS Per share dataNAI.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.57%, NAI has a reasonable but not impressive dividend return.
  • NAI's Dividend Yield is a higher than the S&P500 average which is at 1.79.
Industry RankSector Rank
Dividend Yield 2.57%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
NAI.AS Yearly Dividends per shareNAI.AS Yearly Dividends per shareYearly Dividends per share 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

  • NAI pays out 162.96% of its income as dividend. This is not a sustainable payout ratio.
DP162.96%
EPS Next 2YN/A
EPS Next 3YN/A
NAI.AS Yearly Income VS Free CF VS DividendNAI.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 0 2M -2M -4M
NAI.AS Dividend Payout.NAI.AS Dividend Payout, showing the Payout Ratio.NAI.AS Dividend Payout.PayoutRetained Earnings

NEW AMSTERDAM INVEST NV

AMS:NAI (2/12/2026, 7:00:00 PM)

8.95

+0.15 (+1.7%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap46.27M
Revenue(TTM)15.63M
Net Income(TTM)1.10M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.57%
Yearly Dividend0.39
Dividend Growth(5Y)N/A
DP162.96%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 31.96
Fwd PE N/A
P/S 2.96
P/FCF 21.13
P/OCF 21.12
P/B 1.09
P/tB 1.09
EV/EBITDA 12.75
EPS(TTM)0.28
EY3.13%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.42
FCFY4.73%
OCF(TTM)0.42
OCFY4.74%
SpS3.02
BVpS8.21
TBVpS8.21
PEG (NY)N/A
PEG (5Y)N/A
Graham Number7.19
Profitability
Industry RankSector Rank
ROA 0.89%
ROE 2.58%
ROCE 7.3%
ROIC 5.55%
ROICexc 5.69%
ROICexgc 5.69%
OM 54.47%
PM (TTM) 7.01%
GM 63.12%
FCFM 14.01%
ROA(3y)-2.71%
ROA(5y)N/A
ROE(3y)-3.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 1.52
Debt/FCF 29.7
Debt/EBITDA 7.59
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 2.53
Cash Conversion 25.73%
Profit Quality 199.82%
Current Ratio 0.69
Quick Ratio 0.69
Altman-Z 0.6
F-Score5
WACC5.93%
ROIC/WACC0.94
Cap/Depr(3y)16.98%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)415.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-63.16%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)82.26%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%99.67%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y92.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1395.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1404.17%
OCF growth 3YN/A
OCF growth 5YN/A

NEW AMSTERDAM INVEST NV / NAI.AS FAQ

What is the ChartMill fundamental rating of NEW AMSTERDAM INVEST NV (NAI.AS) stock?

ChartMill assigns a fundamental rating of 1 / 10 to NAI.AS.


What is the valuation status of NEW AMSTERDAM INVEST NV (NAI.AS) stock?

ChartMill assigns a valuation rating of 0 / 10 to NEW AMSTERDAM INVEST NV (NAI.AS). This can be considered as Overvalued.


What is the profitability of NAI stock?

NEW AMSTERDAM INVEST NV (NAI.AS) has a profitability rating of 1 / 10.


How financially healthy is NEW AMSTERDAM INVEST NV?

The financial health rating of NEW AMSTERDAM INVEST NV (NAI.AS) is 0 / 10.